Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ETCE | ISIN: US74019L6020 | Ticker-Symbol: TGK
NASDAQ
05.06.25 | 20:20
11,250 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PRECIPIO INC Chart 1 Jahr
5-Tage-Chart
PRECIPIO INC 5-Tage-Chart

Aktuelle News zur PRECIPIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.05.Precipio anticipates return to positive cash flow in Q2 or Q3 2025 amid robust margin gains and regulatory milestones3
15.05.Precipio reports Q1 results1
14.05.Precipio Q1 Earnings Preview1
PRECIPIO Aktie jetzt für 0€ handeln
14.05.Precipio, Inc.: Precipio Announces its Q1-2025 Financial Results99NEW HAVEN, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company's...
► Artikel lesen
14.05.Precipio, Inc. - 10-Q, Quarterly Report-
06.05.Precipio, Inc. - 8-K, Current Report1
01.05.Precipio, Inc.: Precipio Announces Q1-2025 Shareholder Update Call1
27.03.Precipio, Inc. - 10-K, Annual Report1
17.03.Precipio, Inc. - 8-K, Current Report5
17.03.Precipio, Inc.: Precipio Announces Q4 and year-end 2024 Shareholder Update Call1
25.02.Precipio, Inc.: Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)128NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it has achieved two important financial goals in the last quarter...
► Artikel lesen
16.01.Precipio, Inc.: Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs3
16.01.Precipio, Inc. - 8-K, Current Report-
16.01.Precipio, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
25.07.24Precipio, Inc.: Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven261NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO)...
► Artikel lesen
17.07.24Precipio, Inc.: Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024195NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that for Q2-2024, its unaudited revenues have grown from $3.4M in...
► Artikel lesen
12.06.24Precipio, Inc.: Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting196NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote...
► Artikel lesen
12.06.24Precipio, Inc.: Precipio Provides Status Update on Current Business Matters328NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) provides the following update to its shareholders on various business...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1